Krishnan Krish S's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Sep 12, 2023
- Accession no.
- 0001298709-23-000020
- Filed
- Sep 12, 2023
- Trade date
- Sep 11, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions. Open-market sales total $6.36M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krishnan Krish SCIK 0001298709 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Common Stock | SSaleDisposed | −5,008 | $125.23F2 | −$627,151.84 | 1,679,330 | Direct | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −5,452 | $126.17F3 | −$687,878.84 | 1,673,878 | Direct | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −1,873 | $127.18F4 | −$238,208.14 | 1,672,005 | Direct | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −10,557 | $128.37F5 | −$1,355,202.09 | 1,661,448 | Direct | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −2,110 | $129.10F6 | −$272,401 | 1,659,338 | Direct | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −5,007 | $125.23F2 | −$627,026.61 | 1,619,199 | Indirect | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −5,452 | $126.17F3 | −$687,878.84 | 1,613,747 | Indirect | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −1,874 | $127.18F4 | −$238,335.32 | 1,611,873 | Indirect | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −10,557 | $128.37F5 | −$1,355,202.09 | 1,601,316 | Indirect | |
| Sep 11, 2023 | Common Stock | SSaleDisposed | −2,110 | $129.10F6 | −$272,401 | 1,599,206 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades ranging from $124.7100 to $125.6950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F3
The transaction was executed in multiple trades ranging from $125.7200 to $126.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F4
The transaction was executed in multiple trades ranging from $126.7200 to $127.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F5
The transaction was executed in multiple trades ranging from $127.7350 to $128.7300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F6
The transaction was executed in multiple trades ranging from $128.7400 to $129.4200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.